Suppr超能文献

免疫球蛋白G4相关性泪囊泪囊肿:一例新病例报告。

Immunoglobulin G4-related lacrimal sac dacryocystocele: A novel case report.

作者信息

Au Sunny Chi Lik, Leung Kai Ching Peter, Chan Edwin, Ko Simon Tak Chuen

机构信息

Department of Ophthalmology, Tung Wah Eastern Hospital, Hong Kong.

出版信息

Am J Ophthalmol Case Rep. 2020 Jun 20;19:100789. doi: 10.1016/j.ajoc.2020.100789. eCollection 2020 Sep.

Abstract

PURPOSE

Immunoglobulin G4-related disease is a systemic fibroinflammatory disease of unknown etiology. Immunoglobulin G4-related ophthalmic disease (IgG4-ROD) can manifest in multiple ways, but lacrimal sac involvement is rare. We present the first case in Chinese population of lacrimal sac IgG4-ROD.

OBSERVATIONS

Lacrimal sac IgG4-ROD is rare, and only 9 cases were reported in literature. Despite reported cases in Asian population, mainly in Japan, there was none from the Chinese population or South Asia. Our index case is a 67-year-old Chinese male, who presented with a left insidious nasolacrimal duct swelling mimicking dacryocystocele. Lacrimal sac IgG4-ROD was diagnosed with radiological, serological, pathological and immunohistochemical evidence. The under-reporting of this disease entity may suggest a benign course of such.

CONCLUSIONS AND IMPORTANCE

This is the first reported case of biopsy proven lacrimal sac definite IgG4-ROD in Chinese patient on English literature. With the limited cases reported in literature, the pathology of Immunoglobulin G4 immune process in lacrimal sac demands further investigation.

摘要

目的

免疫球蛋白G4相关疾病是一种病因不明的全身性纤维炎症性疾病。免疫球蛋白G4相关眼病(IgG4-ROD)可有多种表现形式,但泪囊受累罕见。我们报告中国人群中首例泪囊IgG4-ROD病例。

观察结果

泪囊IgG4-ROD罕见,文献中仅报道了9例。尽管在亚洲人群(主要是日本)中有病例报道,但中国人群或南亚地区尚无相关报道。我们的索引病例是一名67岁的中国男性,表现为左侧隐匿性鼻泪管肿胀,类似泪囊膨出。通过放射学、血清学、病理学和免疫组织化学证据确诊为泪囊IgG4-ROD。该疾病实体报告不足可能提示其病程呈良性。

结论与意义

这是英文文献中首次报道的经活检证实的中国患者泪囊明确IgG4-ROD病例。鉴于文献报道的病例有限,泪囊中免疫球蛋白G4免疫过程的病理学需要进一步研究。

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验